Factors that retard remyelination in multiple sclerosis with a focus on TIP30: A novel therapeutic target

Expert Opinion on Therapeutic Targets

Volumn 13, Issue 12, 2009, Pages 1375-1386

  Nakahara, Jin ^a   Aiso, Sadakazu ^a   Suzuki, Norihiro ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

differentiation arrest; importin ; multiple sclerosis; nucleocytoplasmic transport; oligodendrocyte precursor cells; remyelination failure; TIP30

Indexed keywords

FC RECEPTOR; HYALURONIC ACID; JAGGED1; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN BASIC PROTEIN; NERVE CELL ADHESION MOLECULE; NOTCH1 RECEPTOR; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN; PROTEIN KINASE FYN; TAT INTERACTING PROTEIN 30; UNCLASSIFIED DRUG; ACYLTRANSFERASE; HTATIP2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADULT; APOPTOSIS; CELL DENSITY; CELL MIGRATION; CELL SURVIVAL; DISEASE DURATION; DISEASE PREDISPOSITION; ENZYME INHIBITION; HUMAN; MULTIPLE SCLEROSIS; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NEUROPATHOLOGY; NUCLEAR LOCALIZATION SIGNAL; NUCLEOCYTOPLASMIC TRANSPORT; OLIGODENDROGLIA; PROTEIN TARGETING; REMYELINIZATION; REVIEW; SIGNAL TRANSDUCTION; CELL DIFFERENTIATION; DRUG EFFECT; GENETICS; MYELIN SHEATH; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACETYLTRANSFERASES; CELL DIFFERENTIATION; HUMANS; MULTIPLE SCLEROSIS; MYELIN SHEATH; OLIGODENDROGLIA; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 75349105353     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728220903307491     Document Type: Review

References (107)

1. Pfrieger FW, Barres BA. What the fly's glia tell the fly's brain. Cell 1995;83:671-4
2. Hartline DK, Colman CR. Rapid conduction and the evolution of giant axons and myelinated fibers. Curr Biol 2007;17:R29-35 (Pubitemid 46027580)
3. Yakovlev PL, Lecours AR. The myelogenetic cycles of regional maturation of the brain. In: Minkowski A, editor, Regional development of brain in early life. Oxford: Blackwell; 1967. p. 3-70
4. ten Donkelaar HJ, Lammens M, Wesseling P, et al Development and malformations of the human pyramidal tract. J Neurol 2004, 251 1429-42 (Pubitemid 40169465)
5. Nagy Z, Westerberg H, Klingberg T. Maturation of white matter is associated with the development of cognitive functions during childhood. J Cogn Neurosci 2004;16:1227-33 (Pubitemid 39274449)
6. Mabbott DJ, Noseworthy M, Bouffet E, et al. White matter growth as a mechanism of cognitive development in children. Neuroimage 2006;33:936-46 (Pubitemid 44584753)
7. Flöel A, deVries MH, Scholz J, et al. White matter integrity in the vicinity of Broca's area predicts grammar learning success. Neuroimage 2009;47:1974-81
8. Bengtsson SL, Nagy Z, Skare S, et al. Extensive piano practicing has regionally specific effects on white matter development. Nat Neurosci 2005;8:1148-50 (Pubitemid 43348132)
9. Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci 2001;22:117-39 (Pubitemid 33771279)
10. Weinshenker BG, Bass B, Rice GP, et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 1989;112:133-46 (Pubitemid 19056478)
11. Ragonese P, Aridon P, Salemi G, et al. Mortality in multiple sclerosis: a review. Eur J Neurol 2008;15:123-7
12. Weiner HL. The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease? Ann Neurol 2009;65:239-48
13. Meuth SG, Kleinschnitz C, Wiendl H. Recent clinical trials and future therapies. J Neurol 2008;255:93-6
14. Duncan ID, Brower A, Kondo Y, et al. Extensive remyelination of the CNS leads to functional recovery. Proc Natl Acad Sci USA 2009;106:6832-6
15. Levine JM, Reynolds R, Fawcett JW. The oligodendrocyte precursor cell in health and disease. Trends Neurosci 2001;24:39-47 (Pubitemid 32332895)
16. Murtie JC, Zhou YX, Le TQ, et al. PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination. Neurobiol Dis 2005;19:171-82 (Pubitemid 40544734)
17. Penderis J, Shields SA, Franklin RJ. Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system. Brain 2003;126:1382-91 (Pubitemid 36644383)
18. Li WW, Penderis J, Zhao C, et al. Females remyelinate more efficiently than males following demyelination in the aged but not young adult CNS. Exp Neurol 2006;202:250-4 (Pubitemid 44344247)
19. Shen S, Sandoval J, Swiss VA, et al. Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency. Nat Neurosci 2008;11:1024-34
20. Franklin RJ, Ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 2008;9:839-55
21. Patrikios P, Stadelmann C, Kutzelnigg A, et al. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 2006;129:3165-72 (Pubitemid 44871433)
22. Goldschmidt T, Antel J, König FB, et al. Remyelination capacity of the MS brain decreases with disease chronicity. Neurology 2009;72:1914-21
23. Trapp BD, Nave KA. Multiple sclerosis: an immune or neurodegenerative disorder? Ann Rev Neurosci 2008;31:247-69
24. Smith KJ. Axonal protection in multiple sclerosis-a particular need during remyelination? Brain 2006;129:3147-9 (Pubitemid 44871431)
25. Chen JT, Collins DL, Atkins HL, et al. Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions. Ann Neurol 2008;63:254-62 (Pubitemid 351355304)
26. Franklin RJM. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 2002;3:705-14
27. Ozawa K, Suchanek G, Breitschopf H, et al. Patterns of oligodendroglia pathology in multiple sclerosis. Brain 1994;117:1311-22
28. Crang AJ, Blakemore WF. Remyelination of demyelinated rat axons by transplanted mouse oligodendrocytes. Glia 1991;4:305-13
29. Groves AK, Barnett SC, Franklin RJ, et al. Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells. Nature 1993;362:453-5 (Pubitemid 23107369)
30. Blakemore WF. Remyelination of CNS axons by Schwann cells transplanted from the sciatic nerve. Nature 1977;266:68-9 (Pubitemid 8050019)
31. Wolswijk G. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J Neurosci 1998;18:601-9 (Pubitemid 28041896)
32. Scolding N, Franklin R, Stevens S, et al. Oligodendrocyte progenitors are present in normal adult human CNS and in the lesions of multiple sclerosis. Brain 1998;121:2221-8 (Pubitemid 28552461)
33. Chang A, Nishiyama A, Peterson J, et al. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 2000;20:6404-12
34. Arnett HA, Fancy SP, Alberta JA, et al. bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science 2004;306:2111-5 (Pubitemid 40007666)
35. Nait-Oumesmar B, Picard-Riera N, Kerninon C, et al. Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors. Proc Natl Acad Sci USA 2007;104:4694-9 (Pubitemid 47186287)
36. Kuhlmann T, Miron V, Cuo Q, et al. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 2008;131:1749-58 (Pubitemid 351957453)
37. Nakahara J, Aiso S. Fc receptor-positive cells in remyelinating multiple sclerosis lesions. J Neuropathol Appl Neurol 2006;65:582-91 (Pubitemid 44288942)
38. Chang A, Tourtellotte WW, Rudick R, Trapp BD. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 2002;346:165-73 (Pubitemid 34438882)
39. Charles P, Hernandez MP, Stankoff B, et al. Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion molecule. Proc Natl Acad Sci USA 2000;97:7585-90 (Pubitemid 30431507)
40. Charles P, Reynolds R, Seilhean D, et al. Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis? Brain 2002;125:1972-9
41. John GR, Shankar SL, Shafit-Zagardo B, et al. Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med 2002;8:1115-21 (Pubitemid 35175966)
42. Stidworthy MF, Genoud S, Li WW, et al. Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination. Brain 2004;127:1928-41 (Pubitemid 39150252)
43. Back SA, Tuohy TM, Chen H, et al. Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat Med 2005;11:966-72 (Pubitemid 41294442)
44. Nakahara J, Kanekura K, Nawa M, et al. Abnormal expression of TIP30 and arrested nucleocytoplasmic transport within oligodendrocyte precursor cells in multiple sclerosis. J Clin Invest 2009;119:169-81
45. Sha Mi, Miller RH, Lee X, et al. LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci 2005;8:745-51 (Pubitemid 43085840)
46. Umemori H, Sato S, Yagi T, et al. Initial events of myelination involve Fyn tyrosine kinase signaling. Nature 1994;367:572-6 (Pubitemid 24055518)
47. Liang X, Draghi NA, Resh MD. Signaling from integrins to Fyn to Rho family GTPases regulates morphologic differentiation of oligodendrocytes. J Neurosci 2004;24:7140-9 (Pubitemid 39096379)
48. Mi S, Hu B, Hahm K, et al. LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat Med 2007;13:1228-33 (Pubitemid 47530642)
49. Mi S, Miller RH, Tang W, et al. Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Ann Neurol 2009;65:304-15
50. Satoh J, Tabunoki H, Yamamura T, et al. TROY and LINGO-1 expression in astrocytes and macrophages/microglia in multiple sclerosis lesions. Neuropathol Appl Neurobiol 2007;33:99-107 (Pubitemid 46090314)
51. Kotter MR, Li WW, Zhao C, Franklin RJ. Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci 2006;26:328-32 (Pubitemid 43089546)
52. Fancy SPJ, Baranzini SE, Zhao C, et al. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev 2009;23:1571-85
53. Foote AK, Blakemore WF. Inflammation stimulates remyelination in areas of chronic demyelination. Brain 2005;128:528-39 (Pubitemid 40380188)
54. Setzu A, Lathia JD, Zhao C, et al. Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells. Glia 2006;54:297-303 (Pubitemid 44316234)
55. Glezer I, Lapointe A, Rivest S. Innate immunity triggers oligodendrocyte progenitor reactivity and confines damage to brain injuries. FASEB J 2006;20:750-2 (Pubitemid 46671203)
56. Hatch MN, Schaumburg CS, Lane TE, Keirstead HS. Endogenous remyelination is induced by transplant rejection in a viral model of multiple sclerosis. J Neuroimmunol 2009:212(1-2):74-81
57. Patani R, Balaratnam M, Vora A, Reynolds A. Remyelination can be extensive in multiple sclerosis despite a long disease course. Neuropathol Appl Neurobiol 2007;33:277-87 (Pubitemid 46701044)
58. Trebst C, König F, Ransohoff R, et al. CCR5 expression on macrophages/microglia is associated with early remyelination in multiple sclerosis lesions. Mult Scler 2008;14:728-33
59. Brusaferri F, Candelise L. Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials. J Neurol 2000;247:435-42 (Pubitemid 30433557)
60. Umemori H, Kadowaki Y, Hirosawa K, et al. Stimulation of myelin basic protein transcription by Fyn tyrosine kinase for myelination. J Neurosci 1999;19:1393-7 (Pubitemid 29088921)
61. White R, Gonsior C, Krämer-Albers EM, et al. Activation of oligodendroglial Fyn kinase enhances translation of mRNAs transported in hnRNP A2-dependent RNA granules. J Cell Biol 2008;181:579-86 (Pubitemid 351717505)
62. Osterhout DJ, Wolven A, Wolf RM, et al. Morphological differentiation of oligodendrocytes requires activation of Fyn tyrosine kinase. J Cell Biol 1999;145:1209-18 (Pubitemid 29293633)
63. Klein C, Kramer EM, Cardine AM, et al. Process outgrowth of oligodendrocytes is promoted by interaction of fyn kinase with the cytoskeletal protein tau. J Neurosci 2002;22:698-707 (Pubitemid 34141750)
64. Belkadi A, LoPresti P. Truncated Tau with the Fyn-biding domain and without the microtubule-binding domain hinders the myelinating capacity of an oligodendrocyte cell line. J Neurochem 2008;107:351-60
65. Wolf RM, Wilkes JJ, Chao MV, Resh MD. Tyrosine phosphorylation of p190 RhoGAP by Fyn regulates oligodendrocyte differentiation. J Neurobiol 2001;49:62-78
66. Jiang S, Avraham HK, Park SY, et al. Process elongation of oligodendrocytes is promoted by the Kelch-related actin-binding protein Mayven. J Neurochem 2005;92:1191-203 (Pubitemid 40344309)
67. Hoshina N, Tezuka T, Yokoyama K, et al. Focal adhesion kinase regulates laminin-induced oligodendroglial process outgrowth. Genes Cells 2007;12:1245-54 (Pubitemid 350042422)
68. Miyamoto Y, Yamauchi J, Tanoue A. Cdk5 phosphorylation of WAVE2 regulates oligodendrocyte precursor cell migration through nonreceptor tyrosine kinase Fyn. J Neurosci 2008;28:8326-37
69. Colognato H, Ramachandrappa S, Olsen IM, Ffrench-Constant C. Integrins direct Src family kinases to regulate distinct phases of oligodendrocyte development. J Cell Biol 2004;167:365-75 (Pubitemid 39435078)
70. Baer AS, Syed YA, Kang SU, et al. Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signaling. Brain 2009;132:465-81
71. Krämer EM, Klein C, Koch T, et al. Compartmentation of Fyn kinase with glycosylphosphatidylinositol-anchored molecules in oligodendrocytes facilitates kinase activation during myelination. J Biol Chem 1999;274:29042-9
72. Nakahara J, Tan-Takeuchi K, Seiwa C, et al. Signaling via immunoglobulin Fcreceptors induces oligodendrocyte precursor cell differentiation. Dev Cell 2003;4:841-52 (Pubitemid 36676036)
73. Cui QL, Zheng WH, Quirion R, Almazan G. Inhibition of Src-like kinases reveals Akt-dependent and-independent pathways in insulin-like growth factor I-mediated oligodendrocyte progenitor survival. J Biol Chem 2005;280:8918-28 (Pubitemid 40409583)
74. Cui QL, Fogle E, Almazan G. Muscarinic acetylcholine receptors mediate oligodendrocyte progenitor survival through Src-like tyrosine kinases and PI3K/Akt pathways. Neurochem Int 2006;48:383-93 (Pubitemid 43327278)
75. Rajasekharan S, Baker KA, Horn KE, et al. Netrin 1 and Dcc regulate oligodendrocyte process branching and membrane extension via Fyn and RhoA. Development 2009;136:415-26
76. Hu QD, Ang BT, Karsak M, et al. F3/Contactin acts as a functional ligand for Notch during oligodendrocyte maturation. Cell 2003;115:163-75 (Pubitemid 37329580)
77. Fried H, Kutay U. Nucleocytoplasmic transport: taking an inventory. Cell Mol Life Sci 2003;60:1659-88 (Pubitemid 37041364)
78. Shtivelman E. A link between metastasis and resistance to apoptosis of variant small cell lung carcinoma. Oncogene 1997;14:2167-73 (Pubitemid 27248228)
79. Xiao H, Tao Y, Greenblatt J, Roeder RG. A cofactor, TIP30, specifically enhances HIV-1 Tat-activated transcription. Proc Natl Acad Sci USA 1998;95:2146-51
80. Ito M, Jiang C, Krumm K, et al. TIP30 deficiency increases susceptibility to tumorigenesis. Cancer Res 2003;63:8763-7 (Pubitemid 38064055)
81. Jiang C, Pecha J, Hoshino I, et al. TIP30 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells through up-regulation of N-cadherin. Cancer Res 2007;67:3574-82 (Pubitemid 46762141)
82. Pecha J, Ankrapp D, Jiang C, et al. Deletion of Tip30 leads to rapid immortalization of murine mammary epithelial cells and ductal hyperplasia in the mammary gland. Oncogene 2007;26:7423-31 (Pubitemid 350158711)
83. Zhao J, Ni H, Ma Y, et al. TIP30/CC3 expression in breast carcinoma: relation to metastasis, clinicopathologic parameters, and p53 expression. Human Pathol 2007;38:293-8 (Pubitemid 46096554)
84. Li X, Zhang Y, Cao S, et al. Reduction of TIP30 correlates with poor prognosis of gastric cancer patients and its restoration drastically inhibits tumor growth and metastasis. Int J Cancer 2009;124:713-21
85. Tong X, Li K, Luo Z, et al. Decreased TIP30 expression promotes tumor metastasis in lung cancer. Am J Pathol 2009;174:1931-9
86. Zhang H, Zhang Y, Duan HO, et al. TIP30 is associated with progression and metastasis of prostate cancer. Int J Cancer 2008;123:810-6 (Pubitemid 352032406)
87. Jiang C, Ito M, Piening V, et al. TIP30 interacts with an estrogen receptor a-interacting coactivator CIA and regulates c-myc transcription. J Biol Chem 2004;279:27781-9 (Pubitemid 38812620)
88. Zhao J, Lu B, Xu H, et al. Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma. Hepatology 2008;48:265-75 (Pubitemid 351975551)
89. Zhao J, Chen J, Lu B, et al. TIP30 induces apoptosis under oxidative stress through stabilization of p53 messenger RNA in human hepatocellular carcinoma. Cancer Res 2008;68:4133-41
90. Shi M, Zhang X, Zhang HW, et al. TIP30 regulates apoptosis-related genes in its apoptotic signal transduction pathway. World J Gastroenterol 2005;11:221-7 (Pubitemid 40125208)
91. Shi M, Yan SG, Xie ST, Wang HN. Tip30-induced apoptosis requires translocation of Bax and involves mitochondrial release of cytochrome c and Smac/DIABLO in hepatocellular carcinoma cells. Biochem Biophys Acta 2008;1783:263-74
92. NicAmhlaoibh R, Shtivelman E. Metastasis suppressor CC3 inhibits angiogenic properties of tumor cells in vitro. Oncogene 2001;20:270-5 (Pubitemid 32150272)
93. Xiao H, Palhan V, Yang Y, Roeder RG. TIP30 has an intrinsic kinase activity required for up-regulation of a subset of apoptotic genes. EMBO J 2000;19:956-63 (Pubitemid 30119821)
94. Baker ME. TIP30, a cofactor for HIV-1 Tat-activated transcription is homologous to short-chain dehydrogenases/reductases. Curr Biol 1999;9:R471 (Pubitemid 29332338)
95. Baker ME, Yan L, Pear MR. Three-dimentional model of human TIP30, a coactivator for HIV-1 Tat-activated transcription, and CC3, a protein associated with metastasis suppression. Cell Mol Life Sci 2000;57:851-8 (Pubitemid 30392041)
96. Omari KE, Bird LE, Nichols CE, et al. Crystal structure of CC3 (TIP30). J Biol Chem 2005;280:18229-36
97. King FW, Shtivelman E. Inhibition of nuclear import by the proapoptotic protein CC3. Mol Cell Biol 2004;24:7091-101 (Pubitemid 39014436)
98. Narita N, Noda I, Ohtsubo T, et al. Analysis of heat-shock related gene expression in head-and-neck cancer using cDNA arrays. Int J Radiat Oncol Biol Phys 2002;53:190-6 (Pubitemid 34465824)
99. Chaudhry MA, Chodosh LA, McKenna WG, Muschel RJ. Gene expression profile of human cells irradiated in G1 and G2 phases of cell cycle. Cancer Lett 2003;195:221-33 (Pubitemid 36588971)
100. Lesur I, Campbell JL. The transcriptome of prematurely aging yeast cells is similar to that of telomerase-deficient cells. Mol Biol Cell 2004;15:1297-312 (Pubitemid 38316236)
101. Lindfors K, Halttunen T, Kainulainen H, Mäki M. Differentially expressed CC3/TIP30 and rab11 along in vivo and in vitro intestinal epithelial cell crypt-villus axis. Life Sci 2001;69:1363-72 (Pubitemid 32758704)
102. Poomthavorn P, Wong S, Higgins S, et al. Activation of prometastatic gene expression program in hypoxic neuroblastoma cells. Endocr Relat Cancer 2009:16(3):991-1004
103. Lu B, Ma Y, Wu G, et al. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma. Clin Cancer Res 2008;14:7405-12
104. Zhang J, Ito H, Wate R, et al. Altered distributions of nucleocytoplasmic transport-related proteins in the spinal cord of a mouse model of amyotrophic lateral sclerosis. Acta Neuropathol 2006;112:673-80 (Pubitemid 44615028)
105. Sheffield LG, Miskiewicz HB, Tannenbaum LB, Mirra SS. Nuclear pore complex proteins in Alzheimer disease. J Neuropathol Exp Neurol 2006;65:45-54
106. Barnett MH, Prineas JW. Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion. Ann Neurol 2004;55:458-68 (Pubitemid 38391962)
107. Metz I, Lucchinetti CF, Openshaw H, et al. Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis. Brain 2007;130:1254-62 (Pubitemid 47355940)